Works matching AU Lee, In-Jung


Results: 5000
    1
    2
    3

    Patients with BRCA mutated ovarian cancer may have fewer circulating MDSC and more peripheral CD8<sup>+</sup> T cells compared with women with BRCA wild-type disease during the early disease course.

    Published in:
    Oncology Letters, 2019, v. 18, n. 4, p. 3914, doi. 10.3892/ol.2019.10731
    By:
    • Lee, Jung-Min;
    • Botesteanu, Dana-Adriana;
    • Tomita, Yusuke;
    • Yuno, Akira;
    • Lee, Min-Jung;
    • Kohn, Elise C.;
    • Annunziata, Christina M.;
    • Matulonis, Ursula;
    • MacDonald, Lauren A.;
    • Nair, Jayakumar R.;
    • Macneill, Kimberley M.;
    • Trepel, Jane B.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer.

    Published in:
    2016
    By:
    • Noonan, Anne M.;
    • Bunch, Kristen P.;
    • Chen, Jin‐Qiu;
    • Herrmann, Michelle A.;
    • Lee, Jung‐Min;
    • Kohn, Elise C.;
    • O'Sullivan, Ciara C.;
    • Jordan, Elizabeth;
    • Houston, Nicole;
    • Takebe, Naoko;
    • Kinders, Robert J.;
    • Cao, Liang;
    • Peer, Cody J.;
    • Figg, W. Douglas;
    • Annunziata, Christina M.;
    • Chen, Jin-Qiu;
    • Lee, Jung-Min
    Publication type:
    journal article
    15
    16
    17
    18
    19

    Cerebellar α<sub>6</sub> -subunit-containing GABA<sub>A</sub> receptors: a novel therapeutic target for disrupted prepulse inhibition in neuropsychiatric disorders.

    Published in:
    2018
    By:
    • Chiou, Lih‐Chu;
    • Lee, Hsin‐Jung;
    • Ernst, Margot;
    • Huang, Wei‐Jan;
    • Chou, Jui‐Feng;
    • Chen, Hon‐Lie;
    • Mouri, Akihiro;
    • Chen, Liang‐Chieh;
    • Treven, Marco;
    • Mamiya, Takayoshi;
    • Fan, Pi‐Chuan;
    • Knutson, Daniel E.;
    • Witzigmann, Chris;
    • Cook, James;
    • Sieghart, Werner;
    • Nabeshima, Toshitaka;
    • Chiou, Lih-Chu;
    • Lee, Hsin-Jung;
    • Huang, Wei-Jan;
    • Chou, Jui-Feng
    Publication type:
    journal article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Comprehensive Characterization of N‐Glycosylation in Darbepoetin Alfa.

    Published in:
    Bulletin of the Korean Chemical Society, 2019, v. 40, n. 10, p. 976, doi. 10.1002/bkcs.11856
    By:
    • Lee, Jung Rok;
    • Choi, Doyoung;
    • Choi, Inseong;
    • Park, Mikyung;
    • Choi, Eunyoung;
    • Lee, Yoon Jung;
    • Park, Jeehye;
    • Yang, Yoo Hee;
    • Ha, Gyong‐Sik;
    • Chul Jin, Hong;
    • Kim, Kwang Pyo
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    A Single-Arm, Open-Label Phase II Study of ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma.

    Published in:
    Oncologist, 2023, v. 28, n. 10, p. 919, doi. 10.1093/oncolo/oyad164
    By:
    • Atkins, Sarah L P;
    • Greer, Yoshimi Endo;
    • Jenkins, Sarah;
    • Gatti-Mays, Margaret E;
    • Houston, Nicole;
    • Lee, Sunmin;
    • Lee, Min-Jung;
    • Rastogi, Shraddha;
    • Sato, Nahoko;
    • Burks, Christina;
    • Annunziata, Christina M;
    • Lee, Jung-Min;
    • Nagashima, Kunio;
    • Trepel, Jane B;
    • Lipkowitz, Stanley;
    • Zimmer, Alexandra S
    Publication type:
    Article
    43
    44
    45
    46

    Reply to: Comments on "Randomized, two‐arm, non‐comparative phase 2 study of olaparib plus cediranib or durvalumab in HRR‐mutated, platinum‐resistant ovarian cancer: A substudy of KGOG 3045".

    Published in:
    International Journal of Cancer, 2024, v. 154, n. 4, p. 764, doi. 10.1002/ijc.34786
    By:
    • Kim, Yoo‐Na;
    • Joung, Je‐Gun;
    • Park, Eunhyang;
    • Kim, Jae‐Weon;
    • Lee, Jung Bok;
    • Lim, Jinyeong;
    • Kim, Sunghoon;
    • Choi, Chel Hun;
    • Kim, Hee Seung;
    • Chung, Jongsuk;
    • Kim, Byoung‐Gie;
    • Lee, Jung‐Yun
    Publication type:
    Article
    47
    48
    49
    50